Deletion of H-ferritin in macrophages mitigates the development of steatohepatitis and hepatocellular carcinoma in mice

Authors:

Abstract
NASH is a type of NAFLD with severe damage such as inflammation and fibrosis, which causes hepatocellular carcinoma. This study explores macrophage-specific iron involvement in NASH using LysM-Cre FthKO mice. Results show that knocking out H-ferritin in macrophages reduces NASH-related inflammation, fibrosis, and oxidative stress compared with wild-type mice. Tumor occurrence was lower in LysM-Cre FthKO mice. These findings suggest that macrophage iron modulation may be a therapeutic target for NASH treatment.
Funding Information
  • MEXT | Japan Society for the Promotion of Science (21K07914)
  • MEXT | Japan Society for the Promotion of Science (24K11388)
  • Lilly | Eli Lilly Japan

This publication has 46 references indexed in Scilit: